AR027937A1 - Tratamiento de condiciones alergicas e inflamatorias - Google Patents
Tratamiento de condiciones alergicas e inflamatoriasInfo
- Publication number
- AR027937A1 AR027937A1 ARP010100482A ARP010100482A AR027937A1 AR 027937 A1 AR027937 A1 AR 027937A1 AR P010100482 A ARP010100482 A AR P010100482A AR P010100482 A ARP010100482 A AR P010100482A AR 027937 A1 AR027937 A1 AR 027937A1
- Authority
- AR
- Argentina
- Prior art keywords
- treatment
- desloratadine
- allergic
- inflammatory conditions
- prevention
- Prior art date
Links
- 230000000172 allergic effect Effects 0.000 title abstract 2
- 208000010668 atopic eczema Diseases 0.000 title abstract 2
- 230000004968 inflammatory condition Effects 0.000 title abstract 2
- JAUOIFJMECXRGI-UHFFFAOYSA-N Neoclaritin Chemical compound C=1C(Cl)=CC=C2C=1CCC1=CC=CN=C1C2=C1CCNCC1 JAUOIFJMECXRGI-UHFFFAOYSA-N 0.000 abstract 4
- 229960001271 desloratadine Drugs 0.000 abstract 4
- 230000036470 plasma concentration Effects 0.000 abstract 2
- 230000002265 prevention Effects 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 1
- 210000002345 respiratory system Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Otolaryngology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
El uso de la desloratadina para la preparacion de un medicamento para el tratamiento y/o prevencion de condiciones alérgicas e inflamatorias de la piel o de las vías respiratorias en un ser humano de 12 anos de edad y mayor que necesita de dicho trat amiento y/o prevencion mediante la administracion de una cantidad de desloratadina, por ejemplo, 5 mg/día durante 10 días, suficiente para producir una concentracion en plasma máxima en estado estable media geométrica de desloratadina en el rango de 2,90 ng/ml a 4,54 ng/ml, preferentemente 3,63 ng/ml, o una concentracion en plasma máxima en estado estable media aritmética de desloratadina en el rango de 3,2 ng/ml a 5,0ng/ml, preferentemente 4 ng/ml.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17991000P | 2000-02-03 | 2000-02-03 | |
US09/760,588 US7405223B2 (en) | 2000-02-03 | 2001-01-16 | Treating allergic and inflammatory conditions |
Publications (1)
Publication Number | Publication Date |
---|---|
AR027937A1 true AR027937A1 (es) | 2003-04-16 |
Family
ID=26875804
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP010100482A AR027937A1 (es) | 2000-02-03 | 2001-02-01 | Tratamiento de condiciones alergicas e inflamatorias |
Country Status (8)
Country | Link |
---|---|
US (2) | US7405223B2 (es) |
EP (1) | EP1251852A1 (es) |
JP (3) | JP2003528823A (es) |
AR (1) | AR027937A1 (es) |
AU (1) | AU2001233259A1 (es) |
CA (1) | CA2398264C (es) |
MX (1) | MXPA02007557A (es) |
WO (1) | WO2001056574A1 (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001045668A2 (en) * | 1999-12-20 | 2001-06-28 | Schering Corporation | Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine |
AU2276801A (en) | 1999-12-20 | 2001-07-03 | Schering Corporation | Extended release oral dosage composition |
US7405223B2 (en) | 2000-02-03 | 2008-07-29 | Schering Corporation | Treating allergic and inflammatory conditions |
DE10036712A1 (de) * | 2000-07-27 | 2002-02-28 | Active Mining Ag | Verfahren zur Bewertung von mit charakteristischen Merkmalen behafteten Prozessen |
US6599913B1 (en) * | 2001-06-29 | 2003-07-29 | Schering Corporation | Treating allergic and inflammatory conditions |
PL1507531T3 (pl) * | 2003-03-12 | 2007-06-29 | Teva Pharma | Trwałe kompozycje farmaceutyczne desloratadyny |
US20140344067A1 (en) * | 2013-05-15 | 2014-11-20 | Joseph M. Connor, IV | Purchase sharing systems |
US10536758B2 (en) * | 2014-10-09 | 2020-01-14 | Thuuz, Inc. | Customized generation of highlight show with narrative component |
US10419830B2 (en) * | 2014-10-09 | 2019-09-17 | Thuuz, Inc. | Generating a customized highlight sequence depicting an event |
US10433030B2 (en) * | 2014-10-09 | 2019-10-01 | Thuuz, Inc. | Generating a customized highlight sequence depicting multiple events |
CN104645899B (zh) * | 2015-02-11 | 2016-08-24 | 郑州大学 | 快速制备天然气水合物的撞击流反应器及配套系统和方法 |
US20180187263A1 (en) | 2017-01-05 | 2018-07-05 | Iowa State University Research Foundation, Inc. | Kits for diagnostic detection and prevention of feedlot bovine respiratory disease |
Family Cites Families (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3536809A (en) | 1969-02-17 | 1970-10-27 | Alza Corp | Medication method |
US3598123A (en) | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
US3916899A (en) | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
US3940485A (en) | 1973-12-12 | 1976-02-24 | Levinson Harold N | Treatment and pre-treatment of dysmetric dyslexia by improving sequential scanning and ocular fixation abilities and therapeutic compounds |
US4008796A (en) | 1974-03-26 | 1977-02-22 | General Concrete Of Canada Limited | Control method for feeding items on a conveyor |
GB1548022A (en) | 1976-10-06 | 1979-07-04 | Wyeth John & Brother Ltd | Pharmaceutial dosage forms |
US4282233B1 (en) | 1980-06-19 | 2000-09-05 | Schering Corp | Antihistaminic 11-(4-piperidylidene)-5h-benzoÄ5,6Ü-cyclohepta-Ä1,2Ü-pyridines |
AU570306B2 (en) | 1984-02-15 | 1988-03-10 | Schering Corporation | 8-chloro-6, 11-dihydro-11-(4-piperidylidene)-5h-benzo (5,6) cyclohepta (1,2-b) pyridine and its salts. |
US4552899A (en) | 1984-04-09 | 1985-11-12 | Analgesic Associates | Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs |
US4783465A (en) | 1984-04-09 | 1988-11-08 | Analgesic Associates | Cough/cold mixtures comprising non-sedating antihistamine drugs |
US4731447A (en) | 1985-05-13 | 1988-03-15 | Schering Corporation | Process for preparing piperidylidene dihydro-dibenzo(a,d)-cycloheptenes or aza-derivatives thereof |
US4804666A (en) | 1985-08-14 | 1989-02-14 | Schering Corporation | Antiallergic 6,11-dihydro-11-(4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-B)pyridines |
JPS6396126A (ja) | 1986-10-13 | 1988-04-27 | Taisho Pharmaceut Co Ltd | 安定化組成物 |
US5089496A (en) | 1986-10-31 | 1992-02-18 | Schering Corporation | Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies |
US4777170A (en) | 1987-02-03 | 1988-10-11 | Heinrich William A | Method to prevent and treat the signs and symptoms of motion sickness |
US4863931A (en) | 1988-09-15 | 1989-09-05 | Schering Corporation | Antihistaminic fluoro substituted benzocycloheptapyridines |
US5019591A (en) | 1989-02-17 | 1991-05-28 | Pennsylvania Research Corporation | Method for treating retinopathy and other small vessel disorders associated with diabetes |
US4990535A (en) | 1989-05-03 | 1991-02-05 | Schering Corporation | Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine |
ZA914764B (en) | 1990-06-22 | 1992-03-25 | Schering Corp | Bis-benzo or benzopyrido cyclohepta piperidene,piperidylidene and piperazine compounds,compositions and methods of use |
AU665341B2 (en) | 1990-12-18 | 1996-01-04 | Wellcome Foundation Limited, The | Agents for potentiating the effects of antitumor agents and combating multiple drug resistance |
MX9202350A (es) | 1991-05-20 | 1992-11-01 | Alza Corp | Composiciones de incrementador de penetracion a la piel que usan monolinoleato de glicerol. |
ES2042421B1 (es) | 1992-05-22 | 1994-08-01 | Uriach & Cia Sa J | Procedimiento para la obtencion de la 8-cloro-11-*1-*(5-metil-3-piridil)metil*-4-piperidiliden*-6,11-dihidro-5h-benzo*5,6*ciclohepta*1,2-b*piridina. |
EP0950412A3 (en) * | 1992-09-24 | 2001-05-16 | Sepracor, Inc. | Compositions for treating allergic disorders using (-) cetirizine |
US5314697A (en) | 1992-10-23 | 1994-05-24 | Schering Corporation | Stable extended release oral dosage composition comprising loratadine and pseudoephedrine |
US5502080A (en) * | 1994-11-01 | 1996-03-26 | Hitzig; Pietr | Combined use of dopamine and serotonin agonists in the treatment of allergic disorders |
DE4442999A1 (de) | 1994-12-02 | 1996-06-05 | Hexal Pharma Gmbh | Pharmazeutische Zusammensetzung mit einem aktiven Loratidin-Metaboliten |
US5595997A (en) | 1994-12-30 | 1997-01-21 | Sepracor Inc. | Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine |
US5839430A (en) * | 1996-04-26 | 1998-11-24 | Cama; Joseph | Combination inhaler and peak flow rate meter |
PE71699A1 (es) | 1997-02-07 | 1999-08-03 | Sepracor Inc | Composicion farmaceutica de descarboetoxiloratadina sin lactosa, no higroscopica y anhidra |
US5900421A (en) | 1997-02-11 | 1999-05-04 | Sepracor Inc. | Methods and compositions for treating allergic asthma and dermatitis using descarboethoxyloratadine |
US5939426A (en) | 1997-02-28 | 1999-08-17 | Sepracor Inc. | Methods for treating urinary incontinence using descarboethoxyloratadine |
US6506767B1 (en) | 1997-07-02 | 2003-01-14 | Schering Corporation | 8-chloro-6,11-dihydro-11-(4-piperidylidine)-5H-benzo[5,6]cyclohepta[1-2-b] pyridine |
UA62976C2 (en) | 1997-07-02 | 2004-01-15 | Schering Corp | Polymorphs of 8-chloro-6,11-dihydro-11-(4-piperidylidene)-5h-benzo[5,6]cyclohepta[1,2-b]pyridine |
WO1999021556A1 (en) | 1997-10-29 | 1999-05-06 | J-Med Pharmaceuticals, Inc. | Antihistamine/decongestant regimens for treating rhinitis |
ID26390A (id) | 1997-12-23 | 2000-12-21 | Schering Corp | Komposisi untuk pengobatan pernapasan dan penyakit kulit sekurangnya terdiri dari satu leukotrien antagonis dan satu antihistamin |
US6132758A (en) | 1998-06-01 | 2000-10-17 | Schering Corporation | Stabilized antihistamine syrup |
KR100420641B1 (ko) | 1998-07-10 | 2004-03-02 | 쉐링 코포레이션 | 8-클로로-6,11-디하이드로-11-(4-피페리딜리덴)-5에이치-벤조[5,6]사이클로헵타[1,2-비]피리딘 경구용 조성물 |
US6423721B1 (en) | 1998-09-10 | 2002-07-23 | Schering Corporation | Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines |
US6051585A (en) | 1998-12-07 | 2000-04-18 | Weinstein; Robert E. | Single-dose antihistamine/decongestant formulations for treating rhinitis |
US6521254B2 (en) | 1998-12-07 | 2003-02-18 | J-Med Pharmaceuticals, Inc. | Single-dose antihistamine/decongestant formulations for treating rhinitis |
US6100274A (en) | 1999-07-07 | 2000-08-08 | Schering Corporation | 8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions |
EP1214072A2 (en) | 1999-09-21 | 2002-06-19 | Schering Corporation | Use of desloratadine for treating allergic and inflammatory conditions |
EP1214071A2 (en) | 1999-09-22 | 2002-06-19 | Schering Corporation | Treating allergic and inflammatory conditions using desloratadine |
US6114346A (en) | 1999-10-22 | 2000-09-05 | Schering Corporation | Treating sleep disorders using desloratadine |
AU2276801A (en) | 1999-12-20 | 2001-07-03 | Schering Corporation | Extended release oral dosage composition |
WO2001045668A2 (en) | 1999-12-20 | 2001-06-28 | Schering Corporation | Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine |
JP2003518045A (ja) | 1999-12-21 | 2003-06-03 | シェーリング コーポレイション | 小児患者におけるアレルギー性状態および炎症性状態の処置のためのデスロラタジンの使用 |
US7405223B2 (en) * | 2000-02-03 | 2008-07-29 | Schering Corporation | Treating allergic and inflammatory conditions |
CA2398261A1 (en) * | 2000-02-03 | 2001-08-09 | Schering Corporation | Treating allergic and inflammatory conditions |
US6599913B1 (en) | 2001-06-29 | 2003-07-29 | Schering Corporation | Treating allergic and inflammatory conditions |
US20030004179A1 (en) | 2002-05-21 | 2003-01-02 | Affrime Melton B | Treating allergic and inflammatory conditions |
-
2001
- 2001-01-16 US US09/760,588 patent/US7405223B2/en not_active Expired - Fee Related
- 2001-02-01 MX MXPA02007557A patent/MXPA02007557A/es active IP Right Grant
- 2001-02-01 AR ARP010100482A patent/AR027937A1/es unknown
- 2001-02-01 CA CA2398264A patent/CA2398264C/en not_active Expired - Lifetime
- 2001-02-01 EP EP01905371A patent/EP1251852A1/en not_active Withdrawn
- 2001-02-01 JP JP2001556473A patent/JP2003528823A/ja active Pending
- 2001-02-01 WO PCT/US2001/003453 patent/WO2001056574A1/en active Application Filing
- 2001-02-01 AU AU2001233259A patent/AU2001233259A1/en not_active Abandoned
-
2008
- 2008-01-23 JP JP2008013167A patent/JP2008110989A/ja active Pending
- 2008-05-30 US US12/155,250 patent/US7902208B2/en not_active Expired - Fee Related
-
2012
- 2012-03-30 JP JP2012080325A patent/JP2012131828A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
CA2398264A1 (en) | 2001-08-09 |
WO2001056574A1 (en) | 2001-08-09 |
US20080262018A1 (en) | 2008-10-23 |
US7902208B2 (en) | 2011-03-08 |
MXPA02007557A (es) | 2002-12-13 |
AU2001233259A1 (en) | 2001-08-14 |
EP1251852A1 (en) | 2002-10-30 |
US20020019409A1 (en) | 2002-02-14 |
US7405223B2 (en) | 2008-07-29 |
JP2008110989A (ja) | 2008-05-15 |
CA2398264C (en) | 2012-08-21 |
JP2012131828A (ja) | 2012-07-12 |
JP2003528823A (ja) | 2003-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200001891T2 (tr) | ASPB28- İnsan ensülini ve kullanımı. | |
PE20011074A1 (es) | Uso de pramipexol en el tratamiento de trastornos de adiccion | |
AR027937A1 (es) | Tratamiento de condiciones alergicas e inflamatorias | |
BR0314763A (pt) | Tratamento de infecções fúngicas | |
BR0015284A (pt) | Formulações de hidrocodona de liberação controlada | |
AU8335291A (en) | Drugs, their manufacture, and their use as painkillers and/or to treat inflammations in humans and animals | |
BR0213358A (pt) | Uso de flibanserina | |
MX9307885A (es) | Aplicacion de la carbamzaepina y oxcarbazepian para la obtencion de medicamentos para el tratamiento de la enfermedad de parkinson y los sindromes parkinsonianos. | |
ES2098920T3 (es) | Formulaciones farmaceuticas para el tratamiento de la dependencia a la nicotina. | |
ATE444061T1 (de) | Transdermales therapeutisches system für parkinson-krankheit mit hohen rotigotin- plasmaspiegeln | |
SE9704644D0 (sv) | New use | |
BRPI0415713A (pt) | mio-inositol hexafosfato para uso tópico | |
ES2244361T1 (es) | Uso del acetato de anecortave para la proteccion de la agudeza visual en pacientes con degeneracion macular asociada a la edad. | |
DE60115432D1 (de) | Apoptotische körper zur verwendung in der behandlung von t-zell-vermittelten- und entzündungserkrankungen | |
HUP0202525A2 (hu) | Mofetil mikofenolát és PEG-IFN-alfa együttes alkalmazása, valamint az azokat tartalmazó gyógyszerkészítmények és kit | |
AR028502A1 (es) | Tratamiento de condiciones inflamatorias alérgicas | |
DE60043886D1 (de) | Formulierungen mit povidon-iod zur behandlung von wunden | |
EP1266663A4 (en) | EOSINOPHILE SPECIFIC APOPTOSE INDUCTORS | |
BR0108261A (pt) | Uso de mirtazapina, método de tratamento de um distúrbio do sono em um indivìduo, e, kit para paciente para o tratamento de distúrbios do sono | |
BR0107881A (pt) | Uso de fsh tratamento de infertilidade | |
WO2004081195A3 (en) | Use of secretin and secretin analogs to treat affective disorders | |
PT1317273E (pt) | Utilizacao de quimera il-6r/il-6 na doenca de huntington | |
Murray | The saint, the king's grandson, the poet, and the Victorian writer: instances of MS when the disease did not have a name | |
TH77900B (th) | ส่วนบอดี้ที่มีฟอสเฟต-กลีเซอรอลที่สามารถยอมรับได้ทางเภสัชกรรม | |
EP1758922B8 (en) | Peptide substance restoring function of respiratory organs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |